All Stories

  1. Secondary Prevention of Ischemic Stroke: More Evidence to Block Two Pathways Affecting Platelet Activation

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, July 2019, Oxford University Press (OUP)

    md paul a gurbel

  2. The optimal antithrombotic regimen to prevent post-CABG adverse events: an ongoing controversy

    Article • European Heart Journal, May 2019, Oxford University Press (OUP)

    md paul a gurbel

  3. The potential of genotype-guided antiplatelet therapy: promises and challenges

    Article • Expert Review of Precision Medicine and Drug Development, November 2018, Taylor & Francis

    md paul a gurbel

  4. Cangrelor for the treatment of patients with Arterial Thrombosis

    Article • Expert Opinion on Pharmacotherapy, August 2018, Taylor & Francis

    md paul a gurbel

  5. Should Antithrombotic Treatment Strategies in East Asians Differ from Caucasians?

    Article • Current Vascular Pharmacology, July 2018, Bentham Science Publishers

    md paul a gurbel, Jae Seok Bae

  6. Combination oral antithrombotic therapy for the treatment of myocardial infarction: recent developments

    Article • Expert Opinion on Pharmacotherapy, April 2018, Taylor & Francis

    md paul a gurbel

  7. Cardiovascular safety of NSAIDs: Additional insights after PRECISION and point of view

    Article • Clinical Cardiology, December 2017, Wiley

    md paul a gurbel

  8. Thromboembolism after WATCHMANTM in a clopidogrel non-responder: A case for concern?

    Article • Catheterization and Cardiovascular Interventions, November 2017, Wiley

    md paul a gurbel

  9. HIV infection, ACS, PCI and high platelet reactivity: ingredients for a perfect thrombotic storm

    Article • European Heart Journal, January 2017, European Society of Cardiology

    md paul a gurbel

  10. State of the art: Oral antiplatelet therapy

    Article • JRSM Cardiovascular Disease, June 2016, SAGE Publications

    md paul a gurbel